Report Overview

The Indian Renal Cancer market size stood at around USD XX Billion in 2019 and is projected to reach USD XX Billion by 2028, exhibiting a CAGR of XX% during the forecast period.

In India, the projected incidence ofkidney cancer is about 2/100,000 population (males) and among females, it is nearly 1/100,000 population.The incidence is expected to rise in India due to increasing life expectancy, rising awareness, better diagnostic facilities and growing prevalence of risk factors such as obesity. Renal cell cancer (also called kidney cancer or renal cell adenocarcinoma) is a disease in which malignant (cancer) cells are found in the lining of tubules (very small tubes) in the kidney.



Market Drivers

Rise in incidence of renal cancer acts as one of the major drivers of the kidney cancer drugs market. Change in lifestyle of people, consumption of tobacco and unhealthy diet are some factors which contribute to the growth of these renal cancer cells. Renal cancer market would grow, owing to factors such as rising obesity, high number of smokers, and reduced physical activities due to changing lifestyle.Advancement of diagnostics equipment increases the lifespan of this demographic and improves the quality of life for those suffering from neurological conditions. Hence, the presence of a large geriatric population pool is considered a vital driver for this industry.